Grifols

Pharmaceutical ManufacturingCatalonia, Spain10001+ Employees

Grifols is a global pharmaceutical manufacturer based in Catalonia, Spain, with origins in Barcelona dating back to 1909. It specializes in plasma-derived medicines and transfusion medicine, developing and delivering therapies and related services in more than 110 countries. Its portfolio covers immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases, aiming to address a spectrum of chronic, rare and life-threatening conditions. 

The company employs a substantial global workforce and emphasizes quality, safety and ethical leadership across its operations, which span more than 30 countries. In 2026, Grifols launched FESILTY, a fibrinogen concentrate, in the United States following FDA approval for treating acute bleeding episodes in patients with congenital fibrinogen deficiency. As a provider of plasma-derived medicines and related biopharmaceuticals, Grifols supports patients, donors and healthcare systems worldwide through its products and services.

Sign up for free to view info

Email Format Employee directory